Brandinium

Trademark search for:

CARE-MAX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-01-03 — Application filed
  • 2003-06-18 — Assigned to examiner
  • 2003-07-01 — Final disposition recorded
  • 2004-02-27 — Assigned to examiner
  • 2004-03-04 — Application abandoned
  • 2004-03-12 — Teas change of correspondence received
  • 2004-03-22 — Paper received
  • 2004-03-22 — Petition to revive-received
  • 2004-07-01 — Incomplete petition notice mailed
  • 2004-07-15 — Paper received
  • 2004-07-15 — Communication received from petitioner
  • 2004-07-28 — Petition to revive-granted
  • 2004-07-30 — Approved for pub - principal register
  • 2004-08-06 — Assigned to lie
  • 2004-08-06 — Law office publication review completed
  • 2004-09-15 — Notice of publication
  • 2004-10-05 — Published for opposition
  • 2004-10-19 — Assigned to examiner
  • 2004-12-28 — Noa mailed - sou required from applicant
  • 2005-05-22 — Teas change of correspondence received
  • 2005-06-27 — Sou teas extension received
  • 2005-06-28 — Sou extension 1 filed
  • 2005-06-30 — Sou extension 1 granted
  • 2005-12-29 — Final status recorded
  • 2006-03-01 — Application abandoned
  • 2006-03-01 — Application abandoned

Owner Information

INVEREXCEL, S.A.
SANTO DOMINGO DO
INVEREXCEL, S.A.
SANTO DOMINGO DO

Correspondent

CHARLES A MUSERLIAN HEDMAN & COSTIGAN
20TH FL
1185 AVE OF THE AMERICAS
NEW YORK, NY 10036

Filing Details

Filing Date:
2003-01-03
Status Date:
2005-12-29
Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.